Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Technology Information Technology Services
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Diagnos Inc
Bullboard Posts
User Avatar Image
(337)
•••
Post by u2bobon Mar 30, 2018 1:45pm
140 Views
Post# 27808508

Novartis CEO pushing toward AI TELEMEDICINE !

Novartis CEO pushing toward AI TELEMEDICINE !Big Pharma AI ...ADK right time right place... early stage pilots to show the effectivness of the software CARA Telemedicine AI new software to employ Blockcain and Cardio onthe way ! This will be ADK's time to shine...imho !

 
 
New Novartis CEO pushes for AI, telemedicine
March 26, 2018 | Cara Livernois



The drug industry has generally been skeptical of tech's potential. But the new CEO insists that "going big on data and digital" will be one of the keys to Novartis' future. "Our odds at Novartis of finding bad decisions, then making the right decisions, go up when we are powered by these machine capabilities and artificial intelligences." He's putting his own sweat into making that happen. The big question is whether he's right, or whether this is just a tech infatuation, and a distraction from Novartis' real mission: making drugs.

www.clinical-innovation.com/topics/mobile-telehealth/new-novartis-ceo-pushes-ai-telemedicine

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities